Bruker Corp has a consensus price target of $81.8 based on the ratings of 11 analysts. The high is $102 issued by UBS on March 1, 2024. The low is $60 issued by Goldman Sachs on July 9, 2024. The 3 most-recent analyst ratings were released by Citigroup, Goldman Sachs, and Stifel on July 10, 2024, July 9, 2024, and May 20, 2024, respectively. With an average price target of $72.33 between Citigroup, Goldman Sachs, and Stifel, there's an implied 16.42% upside for Bruker Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/10/2024 | Buy Now | 28.76% | Citigroup | Patrick Donnelly | $95 → $80 | Maintains | Buy | Get Alert |
07/09/2024 | Buy Now | -3.43% | Goldman Sachs | Matthew Sykes | $72 → $60 | Maintains | Sell | Get Alert |
05/20/2024 | Buy Now | 23.93% | Stifel | Daniel Arias | $81 → $77 | Maintains | Hold | Get Alert |
05/20/2024 | Buy Now | 44.86% | B of A Securities | Derik De Bruin | $95 → $90 | Maintains | Buy | Get Alert |
04/10/2024 | Buy Now | 19.11% | Goldman Sachs | Matthew Sykes | $66 → $74 | Maintains | Sell | Get Alert |
03/01/2024 | Buy Now | 64.17% | UBS | John Sourbeer | $94 → $102 | Maintains | Buy | Get Alert |
02/15/2024 | Buy Now | 51.3% | UBS | John Sourbeer | $86 → $94 | Maintains | Buy | Get Alert |
02/14/2024 | Buy Now | 44.86% | JP Morgan | Rachel Vatnsdal | $60 → $90 | Upgrade | Neutral → Overweight | Get Alert |
02/14/2024 | Buy Now | 52.91% | Citigroup | Patrick Donnelly | $80 → $95 | Maintains | Buy | Get Alert |
02/14/2024 | Buy Now | 30.37% | Stifel | Daniel Arias | $63 → $81 | Maintains | Hold | Get Alert |
12/19/2023 | Buy Now | 15.89% | Wells Fargo | Timothy Daley | → $72 | Initiates | → Equal-Weight | Get Alert |
12/13/2023 | Buy Now | — | Wolfe Research | Doug Schenkel | — | Initiates | → Outperform | Get Alert |
10/17/2023 | Buy Now | 4.62% | JP Morgan | Rachel Vatnsdal | $70 → $65 | Maintains | Neutral | Get Alert |
05/05/2023 | Buy Now | 52.91% | Citigroup | Patrick Donnelly | $90 → $95 | Maintains | Buy | Get Alert |
04/19/2023 | Buy Now | 12.67% | Goldman Sachs | Matthew Sykes | $63 → $70 | Maintains | Sell | Get Alert |
04/18/2023 | Buy Now | 12.67% | Goldman Sachs | — | $63 → $70 | Maintains | Sell | Get Alert |
02/10/2023 | Buy Now | 44.86% | Citigroup | Patrick Donnelly | $80 → $90 | Maintains | Buy | Get Alert |
10/21/2022 | Buy Now | 12.67% | UBS | John Sourbeer | → $70 | Initiates | → Buy | Get Alert |
08/22/2022 | Buy Now | 28.76% | Citigroup | Patrick Donnelly | $70 → $80 | Upgrade | Neutral → Buy | Get Alert |
05/05/2022 | Buy Now | 40.03% | SVB Leerink | Puneet Souda | $85 → $87 | Maintains | Outperform | Get Alert |
04/13/2022 | Buy Now | -3.43% | Goldman Sachs | — | $73 → $60 | Maintains | Sell | Get Alert |
02/14/2022 | Buy Now | 36.81% | SVB Leerink | Puneet Souda | $84 → $85 | Maintains | Outperform | Get Alert |
11/02/2021 | Buy Now | 44.86% | Wells Fargo | Dan Leonard | — | Maintains | Equal-Weight | Get Alert |
09/09/2021 | Buy Now | 60.95% | SVB Leerink | Puneet Souda | — | Maintains | Outperform | Get Alert |
08/03/2021 | Buy Now | 36.81% | Wells Fargo | Dan Leonard | — | Maintains | Equal-Weight | Get Alert |
The latest price target for Bruker (NASDAQ:BRKR) was reported by Citigroup on July 10, 2024. The analyst firm set a price target for $80.00 expecting BRKR to rise to within 12 months (a possible 28.76% upside). 13 analyst firms have reported ratings in the last year.
The latest analyst rating for Bruker (NASDAQ:BRKR) was provided by Citigroup, and Bruker maintained their buy rating.
The last upgrade for Bruker Corp happened on February 14, 2024 when JP Morgan raised their price target to $90. JP Morgan previously had a neutral for Bruker Corp.
There is no last downgrade for Bruker.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bruker, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bruker was filed on July 10, 2024 so you should expect the next rating to be made available sometime around July 10, 2025.
While ratings are subjective and will change, the latest Bruker (BRKR) rating was a maintained with a price target of $95.00 to $80.00. The current price Bruker (BRKR) is trading at is $62.13, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.